Journals / Harran Üniversitesi Tıp Fakültesi Dergisi / 2008 / Cilt: 5 - Sayı: 3

The Effect Of Resveratrol On Vasospasm In Experimental Triple Subarachnoid Hemorrhage Model

Deneysel Üçlü Subaraknoid Kanama Modelinde Resveratrolün Vazospazm Üzerine Etkisi

Pages
9–15
Publication Date
2008-12-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the SAH + group in which resveratrol was used for treatment Group 6 , comparison of the basilar artery diameter obtained at the 15th minute and 72nd hour of SAH showed significant improvement p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Backgraund Cerebral vasospasm which follows aneurysmal subarachnoid hemorrhage has an important impact on mortality and morbidity.
📊
Key Findings & Data:Methods In this study, the effects of resveratrol and its solvent dimethyl sulfoxide DMSO on the basilar arterial vasospasm were evaluated by angiography in an experimental triple subarachnoid hemorrhage model which was performed on 6 groups of New Zealand rabbits.
💡
Conclusion & Impact:In the SAH + group in which resveratrol was used for treatment Group 6 , comparison of the basilar artery diameter obtained at the 15th minute and 72nd hour of SAH showed significant improvement p
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Resveratrol · serebral vasospasm · anjiyografi

Abstract

Backgraund Cerebral vasospasm which follows aneurysmal subarachnoid hemorrhage has an important impact on mortality and morbidity. Despite many studies, the exact etiology and pathogenesis of cerebral vasospasm have yet to be fully understood and an appropriate treatment method has not yet been identified. In this study, the effects of resveratrol on acute phase of vasospasm, which was developed in the basilar artery by a triple subarachnoid hemorrhage SAH model, were examined angiographically in rabbits. Methods In this study, the effects of resveratrol and its solvent dimethyl sulfoxide DMSO on the basilar arterial vasospasm were evaluated by angiography in an experimental triple subarachnoid hemorrhage model which was performed on 6 groups of New Zealand rabbits. Each group consisting of 8 rabbits and forty-eight rabbits were studied totally. Results Statistical analysis to compare measurements before and after resveratrol in SAH - rabbits Group 3 revealed no difference p>0.05 . In the SAH + group in which resveratrol was used for treatment Group 6 , comparison of the basilar artery diameter obtained at the 15th minute and 72nd hour of SAH showed significant improvement p

Özet

Amaç Anevrizmal subaraknoid kanamayı takiben gelişen serebral vazospazmın mortalite ve morbidite üzerinde önemli etkileri vardır. Yapılmış olan pek çok çalışmaya rağmen serebral vazospazmın kesin nedeni ve etiyolojisi bilinmemektedir ve uygun bir tedavi yöntemi de henüz belirlenmemiştir. Bu çalışmada resveratrolün üçlü subaraknoid kanama SAK modeli ile tavşan baziler arterinde oluşturulan akut serebral vazospazm üzerine etkisi anjiyografik olarak incelenmiştir Gereç ve yöntem Bu çalşımada 6 grup Yeni Zelanda tavşanında deneysel olarak oluşturulan üçlü subaraknoid kanama modelinde resveratrol ve çözücüsü dimetil sülfoksitin baziler arterdeki vazospazm üzerine etkisi anjiyografi ile değerlendirilmiştir. Her grupta 8 tavşan bulunuyordu ve toplam 48 tavşan çalışmaya dahil edildi. Bulgular SAK - tavşanlarda 3. Grup resveratrol öncesi ve sonrası ölçümler arasında istatistiksel olarak bir fark yoktu p>0.05 . tedavi için resveratrolün kullanıldığı SAK + grupta 6. Grup 15. Dakika ve 72. Saatte elde edilen baziler arter çapları karşılaştırıldığında anlamlı bir düzelme olduğu görüldü p

🔖

Cite This Article

TORUN, F., TUNA, H., SANCAK, T., DEMIREL, E., BAGDATOGLU, C., EGEMEN, N. (2008). The Effect Of Resveratrol On Vasospasm In Experimental Triple Subarachnoid Hemorrhage Model. Harran Üniversitesi Tıp Fakültesi Dergisi, Cilt: 5 - Sayı: 3, 9–15. https://ajindex.com/articles/22626

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Heros RC, Zervas NT, Varsos V. Cerebral vasospasm after subarachnoid hemorrhage: an update. Ann Neurol, 1983; 14: 599-608. Cook DA. Mechanisms of cerebral vasospasm in subarachnoid hemorrhage. Pharmacol Ther, 1995; 66: 259-284.
  2. Bell TE, Kongable GL. Innovations in aneurysmal intracisternal t-PA for the prevention of vasospasm. J Neurosci Nurs, 1996; 28: 107- 113. hemorrhage: 4. Miburn JM, Moran CJ, Cross DT. Increase in diameters of vasospastic intracranial arteries by intraarterial papaverine administration. J Neurosurg, 1998; 88: 38-42.
  3. Elmali N, Esenkaya I, Harma A, et al. Effect of resveratrol in experimental osteoarthritis in rabbits. Inflamm Res, 2005; 54: 158–162. 6. Goldberg D, Tsang E, Karuanchiri A, et al. Method to assay the concentrations of phenolic constituents of biological interest in wines. Anal Chem, 1996; 68: 1688–1694.
  4. Das S, Alagappan VK, Bagchi D, et al. Coordinated induction of iNOS-VEGF-KDR- eNOS after resveratrol consumption: a potential preconditioning Pharmacol, 2005; 42: 281-289. resveratrol the heart. Vascul 8. Bhat KPL, Kosmeder JW, Pezzuto JM. Biological Antioxid Redox Signal, 2001; 3:1041–1064. of resveratrol. 9. Kimura Y. New anticancer agents: in vitro and in vivo evaluation of the antitumor and antimetastatic actions of various compounds isolated from medicinal plants. In Vivo, 2005;19: 37-60.
  5. Dobrydneva Y, Williams RL, Blackmore PF. Trans-Resveratrol inhibits calcium influx in thrombin-stimulated human platelets. Br J Pharmacol, 1999; 128:149–157.
  6. Sancak T, Silav G, Egemen N, Aldur M. Subarachnoid heamorrhage-induced chronic cerebral vasospasm in the rabbit: IV-DSA versus IA-DSA.Acta Neurochir (Wien) 2002; 144: 929-931.
  7. Wang Q, Xu J, Rottinghaus GE, et al. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res, 2002; 958: 439–447.
  8. Sinha K, Chaudhary G, Gupta YK. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci, 2002; 71: 655–665.
  9. Kassel NF, Peerless SJ, Durward QJ. Treatment vasospasm expansion and induced arterial hypertension. Neurosurg, 1982; 11: 337-343.
  10. Yano K, Kuroda T, Tanabe Y. Preventive therapy against delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: trials of thromboxane A2 synthetase inhibitor and hyperdynamic therapy. Acta Neurochir (Wien), 1993; 125: 15-19.
  11. Feigin VL, Rinkel GJE, Algra A. Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage. Neurology, 1998; 50: 87